A18D (p.Ala18Asp) variant of KRAS (GTPase KRas)

A18D (p.Ala18Asp) in KRAS (GTPase KRas) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.85 / 1. The record also includes population frequency data, experimental measurements, and structural context.

A18D (p.Ala18Asp) variant details